Back
Comstock, Inc. 10K Form
Buy
60
LODE
Comstock, Inc.
Last Price:
$3.75
Seasonality Move:
71.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-14 | 10Q | LODE/Comstock, Inc. Quarterly |
| 2020-05-07 | 10Q | LODE/Comstock, Inc. Quarterly |
| 2020-03-30 | 10K | LODE/Comstock, Inc. Annual |
| 2019-11-04 | 10Q | LODE/Comstock, Inc. Quarterly |
| 2019-08-14 | 10Q | LODE/Comstock, Inc. Quarterly |
| 2019-06-20 | 10Q | LODE/Comstock, Inc. Quarterly |
Receive LODE News And Ratings
See the #1 stock for the next 7 days that we like better than LODE
LODE Financial Statistics
Sales & Book Value
| Annual Sales: | $3M |
|---|---|
| Cash Flow: | $-9.6M |
| Price / Cash Flow: | 103.77 |
| Annual Sales: | $2.31 |
| Price / Book: | 1.51 |
Profitability
| EPS (TTM): | -1.92180 |
|---|---|
| Net Income (TTM): | $-52.6M |
| Gross Margin: | $-143.8K |
| Return on Equity: | -65.65% |
| Return on Assets: | -41.21% |
Comstock, Inc. Earnings Forecast
Key Comstock, Inc. Financial Ratios
-
The Gross Profit Margin over the past 21 years for LODE is -4.77%.
-
The Selling, General & Administrative Expenses for LODE have been equal to 421.16% of Gross Profit Margin.
-
The Research & Development expenses have been 633.19% of Revenue.
-
The Net Earning history of LODE is -1,770.54% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 15 years.
Comstock, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | LODE |
| CUSIP: | 205750 |
| Website: | comstock.inc |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 2.54 |
| Quick Ratio: | 2.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.88 |
|---|---|
| Forward P/E Ratio: | 61.11 |
LODE Technical Analysis vs Fundamental Analysis
Buy
60
Comstock, Inc. (LODE)
is a Buy
Is Comstock, Inc. a Buy or a Sell?
-
Comstock, Inc. stock is rated a BuyThe current Comstock, Inc. [LODE] share price is $3.48. The Score for LODE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.